Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
Taiwan · Delayed Price · Currency is TWD 39.05
-0.90 (-2.25%)
May 29, 2026, 1:30 PM CST
TPE:1762 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -160.56 | -243.85 | 53.03 | 264.91 | 465.87 | 400.78 |
Depreciation & Amortization | 189.15 | 191.35 | 199.16 | 193.01 | 169.05 | 131.99 |
Loss (Gain) From Sale of Assets | - | - | -0.61 | - | 0.7 | - |
Loss (Gain) From Sale of Investments | -16.92 | -16.92 | 15.42 | -10.77 | -9.59 | -3.27 |
Loss (Gain) on Equity Investments | -64.91 | -57.25 | -44.87 | -36.51 | -51.1 | -50.1 |
Provision & Write-off of Bad Debts | - | - | - | - | -18.35 | 18.35 |
Other Operating Activities | 18.73 | -8.54 | -9.96 | -13.22 | 62.94 | -41.36 |
Change in Accounts Receivable | -79.93 | 101.86 | 53.7 | 52.99 | 96.39 | -40.16 |
Change in Inventory | 321.68 | 277.7 | 242.03 | -391.07 | -66.1 | -272.61 |
Change in Accounts Payable | 35.51 | -11.2 | -62.92 | -39.97 | 65.5 | -18.95 |
Change in Unearned Revenue | -72.85 | -80.63 | 94.15 | -11.05 | -20.04 | 70.33 |
Change in Other Net Operating Assets | -15.16 | -11.43 | -71.47 | -85.82 | 35.52 | 15.17 |
Operating Cash Flow | 156.27 | 142.61 | 467.65 | -66.27 | 733.78 | 219.18 |
Operating Cash Flow Growth | -79.57% | -69.50% | - | - | 234.79% | 58.55% |
Capital Expenditures | -40.34 | -61.37 | -103.09 | -450 | -374.66 | -403.36 |
Sale of Property, Plant & Equipment | - | - | 0.61 | - | - | - |
Sale (Purchase) of Intangibles | -1.1 | -0.96 | -1.61 | -1.55 | -1.52 | -2.09 |
Investment in Securities | -7.35 | -0.1 | - | - | - | -399.96 |
Other Investing Activities | -9.89 | 0.63 | 3.98 | -9.77 | - | 2.66 |
Investing Cash Flow | -58.68 | -61.8 | -100.1 | -461.32 | -376.18 | -802.75 |
Short-Term Debt Issued | - | 50 | - | 400 | - | 150 |
Long-Term Debt Issued | - | 200 | - | 400 | 1,600 | 1,200 |
Total Debt Issued | 299.9 | 250 | - | 800 | 1,600 | 1,350 |
Short-Term Debt Repaid | - | - | -350 | - | -50 | - |
Long-Term Debt Repaid | - | -302.77 | -3.67 | -202.6 | -1,702 | -602.71 |
Total Debt Repaid | -352.4 | -302.77 | -353.67 | -202.6 | -1,752 | -602.71 |
Net Debt Issued (Repaid) | -52.5 | -52.77 | -353.67 | 597.4 | -152.21 | 747.29 |
Repurchase of Common Stock | -18.53 | -18.53 | - | - | - | - |
Common Dividends Paid | -14.74 | -14.74 | -62.05 | -100.83 | -100.83 | -116.34 |
Other Financing Activities | - | - | - | - | -0.28 | -0.33 |
Financing Cash Flow | -85.76 | -86.03 | -415.72 | 496.57 | -253.32 | 630.62 |
Foreign Exchange Rate Adjustments | -0.47 | -0.61 | 0.87 | -0.02 | 1.09 | -0.42 |
Net Cash Flow | 11.36 | -5.84 | -47.29 | -31.05 | 105.36 | 46.63 |
Free Cash Flow | 115.93 | 81.24 | 364.57 | -516.27 | 359.12 | -184.18 |
Free Cash Flow Growth | -83.04% | -77.72% | - | - | - | - |
Free Cash Flow Margin | 11.91% | 10.09% | 27.06% | -24.74% | 16.96% | -9.52% |
Free Cash Flow Per Share | 2.10 | 1.46 | 6.48 | -6.61 | 4.58 | -2.35 |
Cash Interest Paid | 16.62 | 16.62 | 21.58 | 29.62 | 10.21 | 3.2 |
Cash Income Tax Paid | 18.07 | 18.07 | 34.89 | 105.27 | 91.85 | 177.3 |
Levered Free Cash Flow | 175.95 | 177.96 | 328.82 | -647.7 | 117.77 | -224.37 |
Unlevered Free Cash Flow | 185.92 | 188.35 | 342.02 | -636.47 | 123.82 | -222.32 |
Change in Working Capital | 190.78 | 277.83 | 255.48 | -463.69 | 114.26 | -237.21 |